From Imaging to Treatment: Initial Clinical Experience with an MRI Linac

Carri Glide-Hurst, PhD DABR, Senior Staff Physicist, Director of Translational Research, Henry Ford Health System and Anthony Doemer, MS DABR, Senior Staff Physicist, Henry Ford Health System


From Imaging to Treatment: Initial Clinical Experience with an MRI Linac


13th September 2017 3pm BST / 10am EDT

FREE TO REGISTER

The advent of MRI-guided radiation therapy has introduced MRI’s powerful soft-tissue contrast into the treatment room, offering strong potential for improved targeting in many disease sites. In February 2017, ViewRay’s MRIdian linear accelerator (linac) received FDA clearance and the first patient treatment using MRIdian® Linac was conducted at Henry Ford Cancer Institute in July 2017. In this webinar, two key physicists involved in this project, Anthony Doemer, MS, and Carri Glide-Hurst, PhD, will present their commissioning and clinical experience. Initial site planning, shielding, and MR safety considerations will be shared. The design aspects and functionality of the double-focused MLC, mechanical, and radiation characterization and validation will be presented. Commissioning of the MRI system, including novel aspects such as distortion assessment and field homogeneity in the presence of the linear accelerator will be highlighted. First clinical images and treatment plans will be shared to highlight the first months of clinical operation.

 

 

Glide hurst carri headshot150

Carri Glide Hurst

Carri K. Glide-Hurst, Ph.D., DABR
Director of Translational Research
Henry Ford Health System
Affiliate Associate Professor
Department of Radiation Oncology
Wayne State University School of Medicine
Detroit, MI

Dr. Glide-Hurst obtained her PhD in Medical Physics from Wayne State University in 2007, and then spent two years in postdoctoral training in the Department of Radiation Oncology at William Beaumont Hospital. She has since been at Henry Ford Health System in Detroit, where she currently holds the position of Director of Translational Research. Her primary clinical and research focus includes the implementation MR simulation (MR-SIM) and MR-guided radiation therapy into Radiation Oncology and treatment planning. This summer, Dr. Glide-Hurst was a key contributor to the commissioning and go-live of the first FDA approved MR-guided treatment at the Henry Ford Cancer Institute. Dr. Glide-Hurst is the co-chair of AAPM Task Group 284 Task Magnetic Resonance Imaging - Simulation in Radiotherapy: Considerations for Clinical Implementation, Optimization, and Quality Assurance. Dr. Glide-Hurst was awarded a 5-year NIH R01 grant on the Development of Anatomical Patient Models to Facilitate MR-only Treatment Planning. She has published >35 peer-reviewed publications and ~100 abstracts related to imaging in Radiation Therapy. She is also active in the ABR, AAPM, and ASTRO.

 

Headshot anthony doemer150

Anthony Doemer

Anthony Doemer obtained his M.S. in Medical Physics from Wayne State University in 2007.  He spent two years in clinical residency training in the Department of Radiation Oncology at Thomas Jefferson University in Philadelphia, Pennsylvania.  Since 2009, he has been a Staff Physicist at the Henry Ford Cancer Institute in Detroit, Michigan.  He currently holds the position of Director of Brachytherapy Physics.